Effect of arginine in diabetic foot ulcers

Phase 3

• Conditions: diabetic foot ulcer.; Type 2 diabetes mellitus with foot ulcer; E11.621

• Registration Number: IRCT20150721023282N16
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 April 2021

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 22

Inclusion Criteria

Grade 1 or 2 diabetic foot ulcers in one or more areas

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
lcer reduction percentage. Timepoint: The beginning of the intervention 7 and 14 days after the intervention. Method of measurement: Ruler.

Secondary Outcome Measures

Name	Time	Method
The number of cases of erythema around the ulcer. Timepoint: The beginning of the intervention 7 and 14 days after the study. Method of measurement: Observation.